v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Preferred Stock
Common Stock
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Capital Reserve
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 1 $ 17,157 $ (749,625) $ 56,952,200 $ 899,917 $ (43,662,547) $ 13,457,103
Balance (in Shares) at Dec. 31, 2024 1,000 171,579,284          
Stock compensation 2,110,467 2,110,467
Stock compensation (in Shares)          
Common stock issued against exercise of warrants $ 1 (1)
Common stock issued against exercise of warrants (in Shares) 10,477          
Conversion of notes payable to equity $ 2,196 30,643,163 30,645,359
Conversion of notes payable to equity (in Shares) 21,966,416          
Net loss 22,714 (5,681,353) (5,658,639)
Balance at Mar. 31, 2025 $ 1 $ 19,354 (726,911) 89,705,829 899,917 (49,343,900) 40,554,290
Balance (in Shares) at Mar. 31, 2025 1,000 193,556,177          
Balance at Dec. 31, 2025 $ 1 $ 19,416 (2,022,660) 95,111,511 899,917 (55,789,934) 38,218,251
Balance (in Shares) at Dec. 31, 2025 1,000 194,165,141          
Proceeds from Private investment in Public Equity, net of issuance costs   $ 578 18,445,920 18,446,498
Proceeds from Private investment in Public Equity, net of issuance costs (in Shares)   5,774,839          
Stock compensation 1,934,303 1,934,303
Stock compensation (in Shares)            
Stock grants $ 19 1,057,390 1,057,409
Stock grants (in Shares) 191,555          
Net loss (1,550,477) (3,582,571) (5,133,048)
Balance at Mar. 31, 2026 $ 1 $ 20,013 $ (3,573,137) $ 116,549,124 $ 899,917 $ (59,372,505) $ 54,523,413
Balance (in Shares) at Mar. 31, 2026 1,000 200,131,535